Press Release

CD BIOSCIENCES INTRODUCES MULTIPLE SOLUTIONS FOR TYPE II CELL DEATH RESEARCH



CD BioSciences has recently launched a suite of research solutions to support scientists in the study of cell death.

FOR IMMEDIATE RELEASE

19/05/2023

CD BioSciences, a US-based CRO serving the global life science research community, has recently launched a suite of research solutions to support scientists in the study of cell death, specifically the type II cell death, including Regulator Identification, Phenotype Analysis, and Chemical Screening.

In multicellular organisms, cell death is a critical and active process for maintaining tissue homeostasis and eliminating potentially harmful cells. There are three major morphologically distinct types of cell death, i.e., apoptosis (type I cell death), autophagic cell death (type II), and necrosis (type III). All three types can be executed by different and sometimes overlapping signaling pathways that respond to specific stimuli.

Autophagic cell death (ACD), also known as type II cell death, is defined morphologically (especially by transmission electron microscopy) as a type of cell death that occurs in the absence of chromatin condensation but is accompanied by massive autophagic vacuolization of the cytoplasm. Although the term ACD is a linguistic invitation to assume that cell death is carried out by autophagy, this term only describes cell death with autophagy.

ACD has been implicated in physiological and pathological events. Although substantial evidence suggests that the inhibition of apoptosis is critical for tumorigenesis, elimination of cancer cells may also be mediated by ACD, and there is evidence that decreased autophagic activity is associated with tumorigenesis. In addition, some recent findings indicate that autophagy plays a dual role in cancer, acting in an environmentally dependent manner.

As a trusted CRO, CD BioSciences now offers global clients a variety of solutions covering all aspects of life science research, including autophagic cell death, ranging from Regulator Characterization, Regulator Identification, Phenotype Analysis, Chemical Screening to Cell Death Characterization.

Examples

Regulator Characterization studies the molecular function of certain regulators in cell death signaling pathways.
Regulator Identification identifies gene regulators participating in certain cell death signaling pathways.
Phenotype Analysis analyzes cellular phenotypes regulated by the gene/protein of interest.
Chemical Screening screens inhibitors or activators of certain types of cell death.
Cell Death Characterization identifies and characterizes the types of cell death under specific conditions.

CD Biosciences is committed to meeting all the needs of researchers in signaling pathway research and will support customers' innovative discoveries by providing high quality reagents and comprehensive solutions. For customers interested in more information on cell death solutions or other signaling pathways, please visit CD BioSciences at https://www.cd-biosciences.com/.

About CD BioSciences

CD BioSciences is a trusted research product supplier and CRO based in New York. With high-quality reagents and comprehensive services, CD BioSciences is a one-stop shop devoted to advancing signaling pathway studies for researchers. The company is committed to fulfilling all demands in the research of signaling pathways and provides high-quality reagents and comprehensive solutions to support innovative discoveries.

Tags:
CD BioSciences  |  type II cell death  |  

---

Organisation Profile:
CD BioSciences is a trusted research product supplier and CRO based in New York. With high-quality reagents and comprehensive services, CD BioSciences is the one-stop shop devoted to researchers making advancements in signaling pathway studies.






Press release contact details for CD BioSciences

NameCD BioSciences
Tel
Fax
Email
Websitehttps://www.cd-biosciences.com/
OrganisationCD BioSciences
Address
Town
County
Postcode




Other press releases from CD BioSciences

CD BioSciences Introduces New Solutions to Support Cell Death Studies
CD BioSciences Launches Scaffold-Based Technologies for 3D Cell Culture
CD BioSciences Launches Hyperspectral Imaging Technology for Food Safety
CD BioSciences Introduces New Cell Death Solutions to Facilitate Research
CD BioSciences Launches Fluorescence Correlation Spectroscopy
CD BioSciences Introduces Various Solutions for Studying Apoptotic Cell Death
CD BioSciences Launches Nanoparticles Imaging Technology for Scientists
CD BioSciences Introduces Multiple Solutions for Type II Cell Death Research
CD BioSciences Launches New Time-Lapse Imaging Services for Scientists
CD BioSciences Launches New Solutions for Microautophagy Research
CD BioSciences Announces New Immunofluorescence-Based Services
CD BioSciences Launches New Solutions for Type III Cell Death Research
CD BioSciences Launches New Super-Resolution Imaging Technology for Biomedical Research
CD BioSciences Announces New Research Solutions on Mitotic Catastrophe
CD BioSciences Announces New Single Molecule Fluorescence Imaging Technology
CD BioSciences Introduces New Metabolic Homeostasis Research Solutions
CD BioSciences Launches New Services to Study Catabolism in Diabetes
CD BioSciences Launches New 3D Tissue Imaging Services
HighRun DataScience Launches Data Science Platform for Global Customers
CD BioSciences Announces New Solutions for Studying Anabolism
CD Biosciences Introduces 3D Image Analysis Services For Bioimaging Research
CD BioSciences Expands Portfolio with Wide Range of Embedding Resins and Kits for Electron and Light Microscopy
CD BioSciences Announces New Solutions for Glucose Homeostasis Research
CD Biosciences Announces Expanded Capabilities for Mechanistic Target of Rapamycin Research in Diabetes and Metabolism
CD Biosciences Launches Substrate-Chromogens for Immunohistochemistry
CD BioSciences Launches New Range of In Vivo Imaging Reagents for Scientific Research
CD BioSciences Introduces IHC Ancillaries for Enhanced Research and Diagnostics
CD BioSciences Announces Comprehensive Range of Nervous System Tissue Microarrays

Disclaimer:
Issuers of the press releases are solely responsible for the content of their press releases. Connect2business.co.uk cannot be held liable for the content posted by others to this website.